Leaflet ENAP 1.25mg / ml solution for injection / infusion

Indicated for: hypertension

Route of administration: injectable / infusion

Substance: enalapril (ACE inhibitor)

ATC: C09AA02 (Cardiovascular system | Ace inhibitors, plain)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Enalapril is a medication used for the treatment of high blood pressure and heart failure. It belongs to the class of angiotensin-converting enzyme (ACE) inhibitors and works by relaxing blood vessels, thereby lowering blood pressure and improving heart function.

The medication is taken orally, usually once or twice daily, and is effective in reducing the risk of cardiovascular complications such as heart attack or stroke.

Side effects may include dizziness, dry cough, fatigue, and, in rare cases, angioedema. It is important to monitor blood pressure and kidney function during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Enalapril. Follow the prescribed dosage and adhere to all medical recommendations.

General data about ENAP 1.25mg / ml

  • Substance: enalapril
  • Date of latest medicines list: 01-06-2026
  • Product code: W58233001
  • Concentration: 1.25mg / ml
  • Pharmaceutical form: solution for injection / infusion
  • Packing volume: 1 ml
  • Product type: Generic medicine
  • Price: 20.93 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 4066/2011/01
  • Shelf life: 3 years-dupa ambalarea dupa comercializare; after reconstitution/diluare-it is used immediately

Pharmaceutical forms available for enalapril

Concentrations available for enalapril

  • 1.25mg/ml
  • 10mg
  • 2.5mg
  • 20mg
  • 5mg

Other substances similar to enalapril

Combinations with other substances

Compensation lists for ENAP 1.25mg / ml KRKA

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

20.93 RON

18.84 RON

2.09 RON

G1 (C1) - Chronic heart failure (NYHA class III or IV)

Price

Copayment

Patient

20.93 RON

20.93 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

20.93 RON

20.93 RON

0.00 RON